GGrantIndex
Sort

64,565 grants matching drug discovery

High Resolution Characterization of Bacterial Epigenomes and Microbiome

$662,721
Gang Fang · Icahn School Of Medicine At Mount Sinai · R35 · FY2021 · GM

Structure-based strategy for developing inhibitors of the kidney chloride channel CLC-Ka

$662,720
Merritt C Maduke · Stanford University · R01 · FY2023 · DK

Advancing Knowledge Discovery for Postoperative Pain Management

$662,684
Tina Hernandez-Boussard · Stanford University · R01 · FY2020 · LM

Bioassay and Ecology Directed Drug Discovery in Panama

$662,512
William H Gerwick · Smithsonian Institution · U01 · FY2006 · TW

Greater Southern California Node of the Clinical Trials Network

$662,494
Yih-Ing Hser · University Of California Los Angeles · UG1 · FY2023 · DA

Drug Discovery and Development Core

$662,459
Gunda I. Georg · University Of Minnesota · P50 · FY2019 · HD

Chemical Biology of the Control of Neddylation by DCN1

$662,443
R Kiplin Guy · University Of Kentucky · R01 · FY2019 · CA

Hit-to-lead optimization for sleeping sickness drug discovery

$662,424
Michael P Pollastri · Northeastern University · R01 · FY2018 · AI

Project 1: Targeting Oncogenic Transcription Factors

$662,404
Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2025 · CA

Project 1: Targeting Oncogenic Transcription Factors

$662,400
Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2023 · CA

Discovery of new cellular targets for small-molecule inhibition of enveloped vir

$662,290
Sean P. J. Whelan · Harvard Medical School · U19 · FY2014 · AI

A Community Mycobacterial Systems Resource

$662,260
Keith M Derbyshire · Wadsworth Center · R01 · FY2016 · AI

A Community Mycobacterial Systems Resource

$662,260
Keith M Derbyshire · Wadsworth Center · R01 · FY2015 · AI

Cpdm: Cloning a Gene that Regulates Eosinophil Function

$662,160
John Paul Sundberg · Jackson Laboratory · R01 · FY2015 · AR

Mechanisms of Endogenous DNA Damage Promotion

$662,153
Susan M. Rosenberg · Baylor College Of Medicine · R01 · FY2021 · CA

Chemical disarming of drug resistance in Mycobacterium tuberculosis

$662,129
Christina Leigh Stallings · Washington University · R01 · FY2019 · AI

Design of precision small molecules targeting RNA repeating transcripts to manipulate and study disease biology

$662,126
Matthew D Disney · Scripps Florida · R35 · FY2021 · NS

SPIGELMAN (UCLA) - MCSP- EXPLORATORY CHEMISTRY (EC)

$662,120
Matthew Surman · Albany Molecular Research, Inc. · N01 · FY2023 · DA

Neuron-Keratinocyte Communication in the Epidermis in Normal and Diabetic Wound Healing

$662,109
Amy S Paller · Northwestern University At Chicago · R01 · FY2022 · AR

Development of P2Y Receptor Ligands

$662,094
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

The role of TMTC4, endoplasmic reticulum Ca2+ flux, and the unfolded protein response in noise-induced hearing loss

$662,079
Dylan Chan · University Of California, San Francisco · R01 · FY2020 · DC

Project 1

$662,060
Raymond C Stevens · Scripps Research Institute, The · U54 · FY2012 · GM

Mitogenic and Oncogenic Regulation of ERK/RSK Signaling

$662,044
John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · CA

Cell density effects on therapeutic sensitivity

$662,027
Jayne Stommel · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Novel mouse models of hepatitis B virus infection and replication

$662,025
Guangxiang George Luo · Wake Forest University Health Sciences · R01 · FY2024 · AI